Mobile system tracks assets

TAKE Supply Chain, formerly ClearOrbit, has unveiled an Internet-based mobile application that automates asset data collection for the tracking and reporting of fixed assets, both capital and physical. The Asset Tracking and Maintenance Solution combines handheld barcode tag printing, RFID scanner technology and a link to the company's existing data system, according to an announcement. Handheld devices permit asset tracking by location, item ID or serial number, feeding inventory and maintenance data to the ERP for a consolidated view of asset status, location and activity.

Additional functionality aids in the planning and scheduling of repair and maintenance, as well as the tracking of associated expenses. The system streamlines a traditionally manually intensive process, the company says.

Separately, TAKE announced last month that global specialty drugmaker Three Rivers Pharmaceuticals had achieved a 50% increase in distribution efficiency and productivity by implementing the Gemini Simplified Interface for Oracle Process Manufacturing to automate warehouse transactions, provide inventory visibility and enable track/trace capabilities across its supply chain. Three Rivers used the Gemini system's mobile radio-frequency scanners for visibility of inbound materials and products throughout its distribution facility. It also used Gemini's compliance label manager to automate labeling and produce barcode labels and RFID tags.

The real-time supply chain execution company formally changed its name from ClearOrbit to TAKE Supply Chain to highlight its transition to a division under parent company TAKE Solutions, which acquired ClearOrbit in 2007.

-read the asset tracking announcement
-read the Three Rivers release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.